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NANOMEDICINE: A NEW ARENA FOR DRUG AND
DIAGNOSTIC DEVICE DEVELOPMENT
 New complex assemblages (drugs and devices) 
operating at the atomic and molecular level that interact 
with cellular and subcellular structures and processes to 
detect and manage diseases
 New pharmacokinetics, pharmacodynamics, and 
efficacy
 Improved safety
 New opportunities to rescue existing potent but toxic 
agents
 “Synthetic biology”
NEW NANOSYSTEMS FROM C-TRAIN
Nanoplatforms Modality Size (nm) Drug Delivery   In vitro       In vivo      Selected Reference    Disclosure/patents
Octane thiol coated gold nanosphere Precursor                                         2                         - - - -
Oleate coated iron oxide nanoparticle Precursor                                       10                         - - - -
Oleate coated manganese oxide nanosphere Precursor 12                         - - - -
Polymer coated Gold nanorods Precursor 30                         - - - -
Nanobialys MR (1H) 120                     Yes                               Yes Yes JACS, 2008, 130(29), 9186         PCT filed
Colloidal Iron Oxide Nanoparticles
(Oil-based) MR (1H) 160 Yes           Yes Yes            Circulation. 2008;118:S_691.       PCT filed
(Sorbitan-based) MR (1H) 120 Yes                    Yes Yes           
Colloidal Manganese Oleate (OL) Nanoparticles MR (1H) 160 Yes                              Yes Yes Chem Comm, 2009, 22, 3234       PCT filed
Colloidal Manganese Oxide Nanoparticles MR (1H) 160 Yes              Yes Yes -do-
1 µm
20% 
100 nm
TEM
Colloidal Radio-opaque Metal Entrapped Polymeric NP
Bismuth and Iodine CT/SCT 160                   No                                   Yes                   Yes JACS, 2009, 131 (in press)   PCT filed
Photoacoustic Gold Nanobeacons PAT 80 Yes                     Yes Yes Angew Chem Int Ed                     PCT filed
2009;48(23):4170-3. 
Photoacoustic Gold Nanobeacons
(Sphere) PAT 160 Yes                                    Yes Yes
(Rod) PAT 160 Yes Yes Yes
Spectral CT(SCT) Nanocolloids
(Bismuth) CT/Dual Energy/SCT 200 Yes               Yes Yes Circulation. 2008;118:S_777       PCT  filed 
(Gold) CT/Dual Energy/SCT 200 Yes
PFC nanoparticles US/MR 19F 180-250 Yes Yes Yes Circulation. 1996;94:3334-3340.     >15 Issued US
Gd PFC nanparticles MR (1H) 180-250 Yes Yes Yes Circulation. 2003;107:1092.             10 Applications   
99mTc or 111In PFC nanoparticle Nuclear (SPECT/CT) 180-250 Yes Yes Yes FASEB J, 2008; 22:2758-2767. 
Gd/99mTc nanoparticles MR: 1H/Nuclear 180- 250 Yes Yes Yes Int J Cancer 2007, 120, 1951-1957.
Eu Paracest PFC Nanoparticle MR Paracest (1H) 180-250 Yes Yes Yes Mag. Res. Med 2006, 56, 1384.
Fluorescent PFC Nanoparticles Optical 180-250 Yes Yes Yes Unpublished
NIR PFC nanoparticles NIR 180-250 Yes                                     Yes Yes Unpublished
Streptokinase PFC Nanoparticles MR (19F)/US 300 Yes                  Yes Yes Nanomedicine , 2007, 2:533–543. 
PFC Nanoparticle-Melittin peptide construct MR/US/Nuclear 180-259 Yes Yes Yes J. Cin. Invest. 2009;119(9):2830-42.
PPACK antithrombin nanoparticles MRI (H and F)/US 180-250 Yes Yes Yes Nanomedicine , 2007, 2:533–543.
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Multispectral (color) CT
“k-edge” imaging: λ dependence
NanoDesign Toolkit
NanoOntology/NanoPK
Perturbation
Magnetic Field
Strain
Photons
Electric Field
Temperature
EXX Application
EMR High Density Hard Drive Read head
EPC High Precision Strain Gauge
EOC Photon Sensor
EEC       Surface Charge Sensing & Imaging
ETC       High Precision Thermometer
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“EXX” (extraordinarily sensitive) nanoarrays for high-
throughput, high-content, high-resolution screening/microscopy
PixelEXX Systems, Inc.
Detecting Very Small Tumors With MRI:
Angiogenesis Targeted Paramagnetic Nanoparticles
(Winter et al.  Cancer Research 2004)
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Nanoparticles bound to VX2 tumor
VX2 TUMOR THERAPY IN RABBITS WITH ΑVΒ3-INTEGRIN 
TARGETED FUMAGILLAN NANOPARTICLES
Control Fumagillin-Treated
MRI of αvβ3
integrin 
binding in 
angiogenesis
3 doses over ~3 weeks in rabbit VX2 tumor
Decreased Tumor Size Decreased Angiogenesis
NEW REGIONAL BUSINESS OPPORTUNITIES
 “National Nanotechnology Initiative”
 Regional “nodes”
 Nano “hotspots”:  US investments of $10’s to $100’s 
millions in state dollars for infrastructure
 Houston, Boston, LA, Chicago, U-C, etc.
 MO: Columbia
 $Trillion business in next few years
 Missouri startups: a handful at present
“FUNDING OF US BIOMEDICAL RESEARCH 2003-2008.”
DORSEY ET AL. JAMA. JAN 13, 2010
 ~ $100 billion/yr
 Industry: >1/2
 NIH: ~1/4
A JOINT VENTURE SPONSORED BY LEADING LOCAL ACADEMIC INSTITUTIONS
(WASHINGTON UNIVERSITY, SAINT LOUIS UNIVERSITY, SAINT LOUIS COMMUNITY
COLLEGE, AND THE UNIVERSITY OF MISSOURI-SAINT LOUIS) WITH THE GOAL OF
ADVANCING THE SAFE AND EFFECTIVE USE OF NANOTECHNOLOGIES TO REDUCE DEATH
AND SUFFERING FROM HUMAN DISEASE.  
THE INSTITUTE WILL ASSEMBLE A BROAD BASE OF REGIONAL EXPERTISE IN THE
AREAS OF NANOTECHNOLOGY, MEDICINE, TECHNOLOGY TRANSFER, AND EDUCATION
TO CREATE NOVEL SOLUTIONS TO COMPLEX HEALTH CARE PROBLEMS
SLIN GOALS
 Translational nexus for 
moving ideas out of academe 
into the commercial sector
 Facilitator of preclinical 
development and clinical trials
 Seed funding for piloting new 
ideas that can grow into 
bigger projects
 Biotech development driver 
locally and nationally
